Applied Digital Stock Rises on AI Cloud Spinoff Plan and ChronoScale Launch 
TSMC Honors Japanese Chip Equipment Makers With 2025 Supplier Awards 
China’s Iron Ore Buyer Pressures Mining Giants as New Supply Shifts Market Power 
Brazilian Oil Workers’ Strike Continues as Key Petrobras Union Rejects Proposal 
Winter Storm Devin Triggers Massive Flight Cancellations and Travel Disruptions Across the U.S. 
Hanwha Signals Readiness to Build Nuclear-Powered Submarines at Philly Shipyard for U.S. Navy 
Winter Storm Disrupts Northeast Travel as Snow and Ice Blanket New York, New Jersey 
L&F Tesla Battery Supply Deal Value Drops Sharply Amid EV Market Slowdown 
Lloyds Banking Group to Close Invoice Factoring Business by End of 2025 
Australia’s Modern Gold Rush: Hobby Prospectors Flock to Victoria’s Golden Triangle 
Citigroup to Exit Russia With Sale of AO Citibank to Renaissance Capital 
Hyundai Recalls Over 51,000 Vehicles in the U.S. Due to Fire Risk From Trailer Wiring Issue 
California DMV Proposes New Safety Rules for Autonomous Vehicles After Waymo Incidents 
Samsung Electronics Secures Annual U.S. Licence for China Chip Equipment Imports in 2026 
Vietnam’s EV Taxi Giant GSM Eyes Hong Kong IPO With $2–3 Billion Valuation 
Boeing Secures $8.6 Billion Pentagon Contract for F-15 Jets for Israel 
Nvidia to Acquire Groq in $20 Billion Deal to Boost AI Chip Dominance 
NEW YORK, Nov. 18, 2016 -- The following statement is being issued by Levi & Korsinsky, LLP:
To: All persons or entities who purchased or otherwise acquired securities of Adeptus Health Inc. (“Adeptus”) (NYSE:ADPT) pursuant and/or traceable to the Company’s secondary public offering on or about July 31, 2015, and purchasers of common shares between April 23, 2015 and November 16, 2015.
You are hereby notified that a securities class action lawsuit has been commenced in the United States District Court for the Eastern District of Texas. If you purchased or otherwise acquired Adeptus securities pursuant to the SPO or between April 23, 2015 and November 16, 2015, your rights may be affected by this action. To get more information go to:
http://www.zlk.com/pslra/adeptus-health
or contact Joseph E. Levi, Esq. either via email at [email protected] or by telephone at (212) 363-7500, toll-free: (877) 363-5972. There is no cost or obligation to you.
The complaint alleges that Adeptus made materially false and/or misleading statements and/or failed to disclose that: (i) the Company was engaging in predatory billing practices, thus exposing Adeptus to numerous risks and possible penalties, including civil and/or criminal sanctions, and exclusion from federal and/or state healthcare programs; (ii) Adeptus’ financial statements had not been prepared in conformity with generally accepted accounting principles; and (iii) contrary to representations about Adeptus’ practice of referring lower acuity patients to urgent care facilities, it routinely treated and excessively billed these patients.
If you suffered a loss in Adeptus Health you have until December 27, 2016 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.
Levi & Korsinsky is a national firm with offices in New York, New Jersey, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation involving financial fraud, and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT: Levi & Korsinsky, LLP Joseph E. Levi, Esq. 30 Broad Street - 24th Floor New York, NY 10004 Tel: (212) 363-7500 Toll Free: (877) 363-5972 Fax: (212) 363-7171 www.zlk.com
